Hospital pharmacy

Human Growth Hormone Market Size, Share & Trends Analysis Report 2023 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 12, 2023
Health, Pharmaceutical, Growth hormone, Global health, Distribution, HGH, Research, Hospital pharmacy, Acquisition, Organization, Food, Incidence, Investment, Application, Dwarfism, Patient, FDA, OPKO Health, USD, Endocrine gland, Pfizer, Novartis, Lilly, Diagnosis, Partnership, Growth, Merck & Co., Parent, Quality of life, Pharmaceutical industry

The "Human Growth Hormone Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Product, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Human Growth Hormone Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Product, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global human growth hormone market size is expected to reach USD 14.28 billion by 2030, growing at a CAGR of 12.3% from 2023 to 2030
    The market is witnessing growth due to an increase in the incidence of growth hormone deficiency and other growth-related disorders.
  • In addition, market growth is being driven by intense competition among key players striving to develop innovative and cost-effective treatment options.
  • The increasing parental concerns regarding the growth of their children are contributing to the rising demand for human growth hormone (HGH) therapy.

Global Allergic Rhinitis Drugs Market Analysis 2023-2028 by Class of Drugs, Route of Administration, Application, and Competitive Analysis - ResearchAndMarkets.com

Retrieved on: 
Monday, July 31, 2023
Health, Chemicals, Plastics, Other Consumer, Consumer, Manufacturing, Other Health, Pharmaceutical, Online, Drug, Intraocular hemorrhage, Laboratory, Recession, Ansoff matrix, Route of administration, COVID-19, Merck Group, Analysis, USD, AstraZeneca, Hospital pharmacy, Administration, Investment, Porter's five forces analysis, Geography, Online pharmacy, Observation, Nasal administration, Antihistamine, Dietary supplement, Retail, Pharmaceutical industry, Application

The "Global Allergic Rhinitis Drugs Market (2023-2028) by Class of Drugs, Route of Administration, Application, and Geography, Competitive Analysis, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Allergic Rhinitis Drugs Market (2023-2028) by Class of Drugs, Route of Administration, Application, and Geography, Competitive Analysis, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The Global Allergic Rhinitis Drugs Market is estimated to be USD 12.06 Bn in 2023 and is expected to reach USD 15.41 Bn by 2028, growing at a CAGR of 5.03%.
  • The report offers a comprehensive evaluation of the Global Allergic Rhinitis Drugs Market.
  • The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix.

Global Infertility Drugs Market Report 2022: Factors Increasing Infertility Cases in Men and Women Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 25, 2023
Health, Pharmaceutical, Online, NICHD, Human services, Office of Inspector General, U.S. Department of Health and Human Services, Estrogen receptor, Online pharmacy, Hypogonadism, Cyst, Social stigma, Pharmacy, Cystic fibrosis, NIH, Bangladesh Technical Education Board, SERM, Obesity, Human development, Patient, Clomifene, Ovulation, PID, Diabetes, Smoking, Research, Bureau of Medical Services (U.S. Department of State), Infertility, Female, Dopamine, Menotropin, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pelvic inflammatory disease, Letrozole, Prevalence, Hospital pharmacy, Endometriosis, Enzyme inhibitor, Men and Women, Urinary tract infection, Birth control, Woman, Gonadotropin

The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.

Key Points: 
  • The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.
  • The growing prevalence of infertility or the difficulty of bringing a baby to term throughout the world is what fuels the market for infertility medications.
  • Based on end-user, the infertility drugs Market is divided into Men and Women.
  • Based on distribution channel, the Infertility Drugs Market is divided into Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy.

Over-The-Counter Consumer Health Products Market Report 2022: Increasing Preference Towards Natural Medicinal Products and Supplements Bolsters Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 24, 2023
Health, General Health, Online, GBP, Use, Cosmetics, Independent Pharmacies in the United States, Investment, Strategic management, Market, Customer support, Pathfinder, Certification, AUD, CHF, Pharmacy, Social impact assessment, USD, Market share analysis, CAD, JPY, Retail, R, Hospital pharmacy, COVID-19, Supermarket, Hypermarket, Business Growth Fund, Value, Dietary supplement, High, Grocery store, EUR

Based on Indications, the market is studied across Gastrointestinal Products, Nutritional Supplements, Oral Care Products, Skin Care Products, and Wound Care Management Products.

Key Points: 
  • Based on Indications, the market is studied across Gastrointestinal Products, Nutritional Supplements, Oral Care Products, Skin Care Products, and Wound Care Management Products.
  • The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Over-The-Counter Consumer Health Products Market.
  • What is the market share of the leading vendors in the Global Over-The-Counter Consumer Health Products Market?
  • What modes and strategic moves are considered suitable for entering the Global Over-The-Counter Consumer Health Products Market?

Global Infertility Drugs Market Report 2022: Sector to Reach $4.8 Billion by 2028 at a 6.2% CAGR

Retrieved on: 
Thursday, January 26, 2023
Online, Endometriosis, Hospital pharmacy, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Infertility, Female, Letrozole, Bangladesh Technical Education Board, Cyst, Ovulation, Office of Inspector General, U.S. Department of Health and Human Services, SERM, Pharmacy, Obesity, Pelvic inflammatory disease, Hypogonadism, Dopamine, Human services, PID, Urinary tract infection, Estrogen receptor, Smoking, Diabetes, Menotropin, Prevalence, NIH, Clomifene, Cystic fibrosis, Enzyme inhibitor, NICHD, Patient, Men and Women, Social stigma, Bureau of Medical Services (U.S. Department of State), Online pharmacy, Human development, Research, Birth control, Gonadotropin, Woman

The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.

Key Points: 
  • The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.
  • The growing prevalence of infertility or the difficulty of bringing a baby to term throughout the world is what fuels the market for infertility medications.
  • Based on distribution channel, the Infertility Drugs Market is divided into Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy.
  • Based on drug class, the infertility drugs market is classified into Gonadotropins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Dopamine Agonists, and Others.

Breast Milk Storage Products Market Size, Share & Trends Analysis Report 2022: A Global $834.06 Million Market by 2030 - Expanding Milk Banks are Predicted to Significantly Increase the Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, January 16, 2023
Parenting, Baby, Maternity, Women, Consumer, Breast milk, Washington University in St. Louis, Transport, Parent, Hospital pharmacy, Fudan University, Transportation Security Administration, Government, Woman, Care, University, Milk, European Foundation, Infant, USD, TSA, Birth control

The global breast milk storage products market size is expected to reach USD 834.06 million by 2030, expanding at a CAGR of 8.28% from 2022 to 2030.

Key Points: 
  • The global breast milk storage products market size is expected to reach USD 834.06 million by 2030, expanding at a CAGR of 8.28% from 2022 to 2030.
  • The expansion of the market for breast milk storage products can be attributed to growing public knowledge of the advantages of breast milk.
  • Globally expanding milk banks are predicted to significantly increase the demand for breast milk storage products including bottles and bags.
  • This is expected to increase the milk donation, thereby impelling the need for breast milk storage products.

LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Featuring Eli Lilly, Pfizer, Johnson & Johnson, Novartis & More - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Health, Pharmaceutical, DSM-IV, Caffeine, Amphetamine, Boston Children's Hospital, Hospital pharmacy, Guanfacine, Country, Safety, Methylphenidate, Hospital, Organization, Clonidine, Adderall, ADHD, Patient, Prevalence, Distribution, Pharmaceutical industry, Lisdexamfetamine

Nearly 65% of diagnosed children with ADHD have also continued to show the symptoms of the disorder well into adulthood.

Key Points: 
  • Nearly 65% of diagnosed children with ADHD have also continued to show the symptoms of the disorder well into adulthood.
  • This further suggested that ADHD can be regarded as a chronic developmental disorder in the nation.
  • The Brazil market dominated the LAMEA Attention Deficit Hyperactivity Disorder Market by Country in 2021; thereby, achieving a market value of $199.4 million by 2028.
  • Additionally, The UAE market would register a CAGR of 7% during (2022-2028).

The Worldwide Antiviral Therapeutics Industry is Expected to Reach $100 Billion by 2027 at a 8.35% CAGR - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Health, Pharmaceutical, Online, Ansoff Matrix, Emotion, Competitive analysis, Hospital pharmacy, Porter's five forces analysis, Protease inhibitor (pharmacology), HIV, Online pharmacy, Independent pharmacy, C1-inhibitor, Risk, Influenza Antiviral Drug Search, Growth, Market development, Observation, SWOT, Geography, USD, Impact, Investment, COVID-19, Pharmaceutical industry, Retail, Risk management, Drug, Distribution

The Global Antiviral Therapeutics Market is estimated to be USD 67.54 Bn in 2022 and expected to reach USD 100.86 Bn by 2027, growing at a CAGR of 8.35%.

Key Points: 
  • The Global Antiviral Therapeutics Market is estimated to be USD 67.54 Bn in 2022 and expected to reach USD 100.86 Bn by 2027, growing at a CAGR of 8.35%.
  • Market dynamics are forces that impact the prices and behaviors of the Global Antiviral Therapeutics Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Antiviral Therapeutics Market.
  • By Drug, the market is classified into Hepatitis Antiviral Drug, Herpes Antiviral Drug, HIV Antiviral Drug, and Influenza Antiviral Drug.

Global Breast Shells Market Size, Share & Trends Analysis Report 2022-2030: Easy Availability over E-Commerce Platforms Bodes well for the Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Consumer, Baby, Maternity, Nursing, Hospital pharmacy, Pressure, Nipple, Skin, Retail, Pregnancy, Woman, Friction, Clothing, Verified-Accredited Wholesale Distributors, USD, Employment, Health insurance, Birth control

The "Breast Shells Market Size, Share & Trends Analysis Report by Sales Channel (Hospital Pharmacy (Inpatient), Retail Store, E-commerce, Wholesaler/Distributor, Direct Purchase), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Breast Shells Market Size, Share & Trends Analysis Report by Sales Channel (Hospital Pharmacy (Inpatient), Retail Store, E-commerce, Wholesaler/Distributor, Direct Purchase), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global breast shells market size is expected to reach USD 91.31 million by 2030, expanding at a CAGR of 3.61%
    Rising breastfeeding rates are fueling the market growth.
  • Additionally, rising levels of employment for women worldwide have increased the demand for easily accessible baby care items such as nursing breast shells.
  • Women's ongoing quest for comfort has encouraged manufacturers to create customizable breastfeeding accessories that fit breast shapes and prevent stains from leaking.

Global Hemoglobinopathies Market Report 2022: Growth of Tissue-Oriented, Safe, and Efficient Gene Editing Technology Bolsters Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Genetics, Health Technology, Health, Online, Disease, Blood, C1-inhibitor, Oxygen, Tissue, Hospital pharmacy, Safety, Nursing, Hospital, Human body, Degenerative disease, Health, Sickle cell disease, Iron, Gene editing, Gene, Carbon, Organization, Pharmacy, Immune system, Growth, Survival, Patient, Distribution, Research, Hemoglobinopathy, Antibody, Market share, ACE, Pharmaceutical industry, Vaccine, Therapy, Thalassemia, Type, Hydroxycarbamide

The Global Hemoglobinopathies Market size is expected to reach $6.0 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period.

Key Points: 
  • The Global Hemoglobinopathies Market size is expected to reach $6.0 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period.
  • The growth of tissue-oriented, safe, and efficient gene editing technology has contributed to the development of various gene therapy types for hemoglobin-related illnesses.
  • Region-wise, the hemoglobinopathies market is analyzed across North America, Europe, Asia Pacific, and LAMEA.
  • The North America region acquired the largest revenue share in the hemoglobinopathies market in 2021.